Dr. Djaballah has several years of industrial experience in early drug discovery gained over the years in pharma and biotech companies. He has extensive experiences in the areas of fluorescence technology, assay development, automation/robotics, HTS, compound & screening data management, software development & novel technologies. Dr Djaballah has been involved in developing and screening several targets in various therapeutic areas, including antibacterials, antivirals, antifungals, diabetes, CNS, cardiovascular, oncology & inflammation. He is currently the director of the high throughput drug screening core facility at Memorial Sloan Kettering Cancer Centre in New York. He obtained his BSc (Hons.) in biochemistry and biotechnology from the University of Birmingham, and his PhD in biochemistry from the University of Leicester, both in England.
Thursday, 20 September 2012 at 08:00
Add to Calendar ▼2012-09-20 08:00:002012-09-20 09:00:00Europe/LondonAcademic Screening Workshop in Baltimore, USABaltimore, USASELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2012-09-20 00:00:002012-09-21 00:00:00Europe/LondonAcademic Screening WorkshopAcademic Screening Workshop in Baltimore, USABaltimore, USASELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2012-09-20 08:00:002012-09-20 09:00:00Europe/LondonAcademic Screening Workshop in Baltimore, USABaltimore, USASELECTBIOenquiries@selectbiosciences.com
